PSC
AGIO icon

Patient Square Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Patient Square Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-133,827
Closed -$5.37M – 29
2025
Q3 		$5.37M Sell
133,827
-5,905
-4% -$222K 1.44% 11
2025
Q2 		$4.65M Hold
139,732
– – 1.68% 13
2025
Q1 		$4.09M Buy
139,732
+18,000
+15% +$597K 1.69% 12
2024
Q4 		$4M Buy
+121,732
New +$5.72M 1.5% 11

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Patient Square Capital's AGIO Position: Q4 2025 in Review

Patient Square Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 133,827 shares — an estimated $5.37M sold.

Patient Square Capital first reported a position in AGIO in Q4 2024 and held it in 4 quarters. The position peaked at $5.37M in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Patient Square Capital reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Patient Square Capital sold 133,827 Agios Pharmaceuticals shares in Q4 2025, an estimated $5.37M.
  • Patient Square Capital first reported a position in Agios Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Patient Square Capital's Agios Pharmaceuticals position peaked at $5.37M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Patient Square Capital's 13F filing for Q4 2025, filed 12 Feb 2026.